Tyler L Borko
Overview
Explore the profile of Tyler L Borko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kammeyer R, Chapman K, Furniss A, Hsieh E, Fuhlbrigge R, Ogbu E, et al.
Lupus
. 2024 Aug;
33(10):1116-1129.
PMID: 39148457
Background: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a poorly understood and heterogeneous manifestation of SLE. Common major NPSLE syndromes include strokes, seizures, myelitis, and aseptic meningitis. Easily obtainable biomarkers are...
2.
Jellins T, Borko T, Otero-Bell R, Arnett K, Saunders S, Poisson S, et al.
J Neurol Sci
. 2024 Mar;
459:122946.
PMID: 38493733
Background: The ability to recognize and address bias is an important communication skill not typically addressed during training. We describe the design of an educational curriculum that aims to identify...
3.
Baxter R, Cabrera-Martinez B, Ghosh T, Rester C, Moreno M, Borko T, et al.
Immunohorizons
. 2024 Mar;
8(3):254-268.
PMID: 38483384
The impact of B cell deficiency on the humoral and cellular responses to SARS-CoV2 mRNA vaccination remains a challenging and significant clinical management question. We evaluated vaccine-elicited serological and cellular...
4.
Celli S, Nash R, Money K, Garza M, Borko T, Mizenko C, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Jan;
11(2):e200197.
PMID: 38170953
Background And Objectives: To describe a case of glycine receptor (GlyR) antibody-positive stiff person syndrome (SPS) treated with autologous hematopoietic stem cell transplant (aHSCT). Methods: This was a multicenter collaboration...
5.
Borko T, Baxter R, Cabrera-Martinez B, Thiruppathi E, Sabalza M, Venkataraman I, et al.
J Neuroimmunol
. 2023 Sep;
383:578192.
PMID: 37666038
Emerging evidence is encouraging and suggests that a substantial proportion of patients without antibody responses (due to anti-CD20 therapy or other etiologies) to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines...